Efficacy and safety of odevixibat in patients with alagille syndrome: top-line results from assert, a phase 3, double-blind, randomized, placebo-controlled study

HEPATOLOGY(2023)

引用 0|浏览18
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要